Following the referral decision of the European Commission on 12 April 2021, the Elsan group notified the Autorité of its plan to take exclusive control of the C2S clinics on 30 April 2021.

Considering that the transaction is not likely to harm competition, the Autorité cleared it without condition. 

Print the page